FDA Warning Letter — RLC Labs Inc.

Case 607596 — FEI 3002523846

The FDA took a Warning Letter action against RLC Labs Inc. on October 9, 2020 (Phoenix, AZ). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
RLC Labs Inc.
Date
October 9, 2020
Fiscal Year
2021
Product Type
Drugs
Center
CDER
Location
Phoenix, AZ (United States)